Wegovy, Novo Nordisk’s weight management drug, was approved for adolescent use in December 2022, and by the next month, the American Academy of Pediatrics recommended weight loss drugs for children with obesity who are at least 12.
Health technology company Komodo Health compiled U.S. insurance claims data to find the prescriptions. The results show a willingness to embrace the GLP-1 but also opportunity for more patients, since forecasts show about 14.7 million U.S. children have obesity, Reuters reported.
Past research has found nearly 1 in 10 children have used nonprescription weight loss products that are ineffective and potentially harmful. In late 2023, a social media trend also promoted “budget Ozempic,” or the use of laxatives and stool softeners for weight loss.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
